Junhai Z, Fei L, Jixiang Z, Huabing X, Cheng T, Weiguo D
Int J Surg. 2024; 111(1):1182-1190.
PMID: 38920326
PMC: 11745644.
DOI: 10.1097/JS9.0000000000001844.
Wang Z, Teng J, Wu W, Dou J, Wong M, Gong Y
Cancer Med. 2023; 12(17):18189-18200.
PMID: 37578430
PMC: 10524075.
DOI: 10.1002/cam4.6399.
Clark G, Godfrey T, Purdie C, Strachan J, Carey F, Fraser C
J Med Screen. 2023; 31(1):21-27.
PMID: 37469171
PMC: 10878005.
DOI: 10.1177/09691413231188252.
Digby J, Fraser C, Clark G, Mowat C, Strachan J, Steele R
J Med Screen. 2023; 30(4):184-190.
PMID: 37229658
PMC: 10629250.
DOI: 10.1177/09691413231175611.
Breekveldt E, Toes-Zoutendijk E, de Jonge L, Spaander M, Dekker E, van Kemenade F
BMC Gastroenterol. 2023; 23(1):45.
PMID: 36814185
PMC: 9948315.
DOI: 10.1186/s12876-023-02670-1.
Do faecal test-based colorectal cancer screening pilots provide data that are reflected in subsequent programmes? Evidence from interval cancer proportions.
Clark G, Steele R, Fraser C
Ann Clin Biochem. 2022; 59(6):450-452.
PMID: 36031942
PMC: 9634330.
DOI: 10.1177/00045632221119714.
Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
Clark G, Fraser C, Strachan J, Steele R
J Med Screen. 2022; 29(4):249-254.
PMID: 35747907
PMC: 9574424.
DOI: 10.1177/09691413221110012.
Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective.
Tran T, Peeters M, Hoeck S, Van Hal G, Janssens S, De Schutter H
Br J Cancer. 2022; 126(7):1091-1099.
PMID: 35022524
PMC: 8980044.
DOI: 10.1038/s41416-021-01694-2.
Cause of Death, Mortality and Occult Blood in Colorectal Cancer Screening.
Kaalby L, Al-Najami I, Deding U, Berg-Beckhoff G, Steele R, Kobaek-Larsen M
Cancers (Basel). 2022; 14(1).
PMID: 35008412
PMC: 8750981.
DOI: 10.3390/cancers14010246.
Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review.
Laszlo H, Seward E, Ayling R, Lake J, Malhi A, Stephens C
Br J Cancer. 2021; 126(5):736-743.
PMID: 34903843
PMC: 8888593.
DOI: 10.1038/s41416-021-01653-x.
Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.
Clark G, Digby J, Fraser C, Strachan J, Steele R
J Med Screen. 2021; 29(1):26-31.
PMID: 34806935
PMC: 8892068.
DOI: 10.1177/09691413211056970.
Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.
Vanaclocha-Espi M, Ibanez J, Molina-Barcelo A, Valverde-Roig M, Nolasco A, Perez-Riquelme F
PLoS One. 2021; 16(7):e0254021.
PMID: 34270590
PMC: 8284629.
DOI: 10.1371/journal.pone.0254021.
Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening.
Kortlever T, van der Vlugt M, Dekker E, Bossuyt P
Prev Med Rep. 2021; 23:101447.
PMID: 34168954
PMC: 8209662.
DOI: 10.1016/j.pmedr.2021.101447.
Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?.
Pellat A, Deyra J, Husson M, Benamouzig R, Coriat R, Chaussade S
Therap Adv Gastroenterol. 2021; 14:17562848211009716.
PMID: 33995581
PMC: 8111528.
DOI: 10.1177/17562848211009716.
The Fast Track FIT study: diagnostic accuracy of faecal immunochemical test for haemoglobin in patients with suspected colorectal cancer.
Turvill J, Turnock D, Cottingham D, Haritakis M, Jeffery L, Girdwood A
Br J Gen Pract. 2021; 71(709):e643-e651.
PMID: 33798091
PMC: 8279659.
DOI: 10.3399/BJGP.2020.1098.
Selection of patients for large mailed fecal immunochemical test colorectal cancer screening outreach programs: A systematic review.
Wang A, Lee B, Patel S, Whitaker E, Issaka R, Somsouk M
J Med Screen. 2021; 28(4):379-388.
PMID: 33683155
PMC: 8423851.
DOI: 10.1177/0969141321997482.
Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
DSouza N, Georgiou Delisle T, Chen M, Benton S, Abulafi M
Gut. 2020; 70(6):1130-1138.
PMID: 33087488
PMC: 8108285.
DOI: 10.1136/gutjnl-2020-321956.
Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer.
Khan A, Klimovskij M, Harshen R
BJS Open. 2020; .
PMID: 32949085
PMC: 7709370.
DOI: 10.1002/bjs5.50346.
Novel Toilet Paper-Based Point-Of-Care Test for the Rapid Detection of Fecal Occult Blood: Instrument Validation Study.
Wang H, Lin T, Chiu S, Lin W, Huang S, Hsieh J
J Med Internet Res. 2020; 22(8):e20261.
PMID: 32763879
PMC: 7472847.
DOI: 10.2196/20261.
Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test.
Pin-Vieito N, Iglesias M, Remedios D, Rodriguez-Alonso L, Rodriguez-Moranta F, Alvarez-Sanchez V
World J Gastroenterol. 2020; 26(1):70-85.
PMID: 31933515
PMC: 6952298.
DOI: 10.3748/wjg.v26.i1.70.